[HTML][HTML] Epidemiological, clinical, patient-reported and economic burden of inflammatory bowel disease (ulcerative colitis and crohn's disease) in Spain: a systematic …
M Barreiro-de Acosta, A Molero, E Artime… - Advances in …, 2023 - Springer
Introduction This study describes the epidemiological, clinical, patient-reported and
economic burden of inflammatory bowel disease (IBD), including Crohn's disease (CD) and …
economic burden of inflammatory bowel disease (IBD), including Crohn's disease (CD) and …
Glycosylation of immunoglobulin G associates with clinical features of inflammatory bowel diseases
Background and Aims Causes of inflammatory bowel diseases are not well understood and
the most prominent forms, Crohn's disease (CD) and ulcerative colitis (UC), are sometimes …
the most prominent forms, Crohn's disease (CD) and ulcerative colitis (UC), are sometimes …
[HTML][HTML] Bacteroides thetaiotaomicron and Lactobacillus johnsonii modulate intestinal inflammation and eliminate fungi via enzymatic hydrolysis of the fungal cell …
R Charlet, C Bortolus, B Sendid, S Jawhara - Scientific reports, 2020 - nature.com
Alterations to the gut microbiota can cause an amplification of the inflammatory response to
intestinal pathogens. We assessed the effect of Bacteroides thetaiotaomicron and …
intestinal pathogens. We assessed the effect of Bacteroides thetaiotaomicron and …
[HTML][HTML] The onset of clinical manifestations in inflammatory bowel disease patients
VG Nóbrega, INN SILVA, BS Brito, J Silva… - Arquivos de …, 2018 - SciELO Brasil
ABSTRACT BACKGROUND: The diagnosis of inflammatory bowel disease is often delayed
because of the lack of an ability to recognize its major clinical manifestations. OBJECTIVE …
because of the lack of an ability to recognize its major clinical manifestations. OBJECTIVE …
[HTML][HTML] Epidemiologic profile of inflammatory bowel disease in Eastern Mediterranean Region (EMRO) countries: a systematic review and meta-analysis
ZM Sanat, H Vahedi, R Malekzadeh, Z Fanni - BMC Public Health, 2024 - ncbi.nlm.nih.gov
Background Inflammatory bowel disease (IBD) consists of two main types: Crohn's disease
(CD) and ulcerative colitis (UC). The epidemiology of IBD patients has not been …
(CD) and ulcerative colitis (UC). The epidemiology of IBD patients has not been …
Portulaca oleracea extracts and their active compounds ameliorate inflammatory bowel diseases in vitro and in vivo by modulating TNF-α, IL-6 and IL-1β signalling
Y Kim, HJ Lim, HJ Jang, S Lee, K Jung, SW Lee… - Food Research …, 2018 - Elsevier
Portulaca oleracea L.(P. oleracea) is an herb that is widely used in traditional medicine to
treat various diseases. However, its effects on inflammatory diseases, such as inflammatory …
treat various diseases. However, its effects on inflammatory diseases, such as inflammatory …
[HTML][HTML] IL-8 antagonist, CXCL8 (3-72) K11R/G31P coupled with probiotic exhibit variably enhanced therapeutic potential in ameliorating ulcerative colitis
W Walana, Y Ye, M Li, J Wang, B Wang… - Biomedicine & …, 2018 - Elsevier
Inflammatory bowel disease (IBD) remains a major health challenge due in part to unsafe
and limited treatment options, hence there is the need for alternatives. CXCL8/interleukin 8 …
and limited treatment options, hence there is the need for alternatives. CXCL8/interleukin 8 …
Prevalence and factors associated with fecal urgency among patients with ulcerative colitis and Crohn's disease in the study of a prospective adult research cohort …
GK Dawwas, H Jajeh, M Shan, AN Naegeli… - Crohn's & Colitis …, 2021 - academic.oup.com
Background In patients with ulcerative colitis (UC) and Crohn's disease (CD), this research
examined the following: prevalence of fecal urgency (hereafter urgency), association of …
examined the following: prevalence of fecal urgency (hereafter urgency), association of …
Plum Prevents Intestinal and Hepatic Inflammation in the Acute and Chronic Models of Dextran Sulfate Sodium‐Induced Mouse Colitis
HJ Kim, JY Eom, SH Choi, HJ Seo… - Molecular Nutrition & …, 2022 - Wiley Online Library
Scope Inflammatory bowel disease (IBD), including ulcerative colitis (UC), is a chronic
recurrent inflammatory disease of the digestive tract and increases the risk of colon cancer …
recurrent inflammatory disease of the digestive tract and increases the risk of colon cancer …
Surface engineered lipid nanoparticle-mediated site-specific drug delivery system for the treatment of inflammatory bowel disease
GK Sinhmar, NN Shah, SU Rawal… - Artificial cells …, 2018 - Taylor & Francis
The major challenge for the treatment of inflammatory bowel disease (IBD) is the
incompetence to deliver the drug molecule selectively at the site of inflammation. Taking this …
incompetence to deliver the drug molecule selectively at the site of inflammation. Taking this …